(2026). Feasibility of tumor-informed circulating tumor DNA for detecting minimal residual disease in surgically resected biliary tract cancer. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Feasibility of Tumor-informed Circulating Tumor DNA for Detecting Minimal Residual Disease in Surgically Resected Biliary Tract Cancer."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Feasibility of Tumor-informed Circulating Tumor DNA for Detecting Minimal Residual Disease in Surgically Resected Biliary Tract Cancer."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.